Table 2.
Case | Immunohistochemical features | ALK | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
desmin | SMA | H-caldesmon | CD30 | CK | EMA | S-100 | myogenin | IHC | FISH | RT-PCR | |
1 | NA | NA | NA | NA | NA | NA | NA | NA | NM+ | + | RANBP2-ALK |
2 | NA | NA | NA | NA | NA | NA | NA | NA | NM+ | + | RANBP2-ALK |
3 | + | + | - | NA | + | NA | - | NA | PN+ | + | RANBP2-ALK |
4 | - | - | NA | - | - | NA | - | NA | NM+ | NA | RANBP2-ALK |
5 | + | - | NA | + | - | - | - | - | NM+ | + | RANBP2-ALK |
6 | + | - | - | + | - | - | - | - | NM+ | + | RANBP2-ALK |
7 | + | + | NA | NA | - | NA | - | - | NM+ | + | NA |
8 | + | - | NA | NA | - | NA | - | - | NM+ | + | NA |
9 | + | + | NA | + | - | - | - | NA | NM+ | NA | NA |
10 | + | - | - | + | - | - | - | - | PN+ | + | NA |
11 | + | NA | NA | NA | NA | NA | NA | NA | NM+ | NA | NA |
12 | + | NA | - | + | NA | NA | NA | - | PN+ | + | NA |
13 | - | + | - | + | - | - | - | - | NM+ | + | NA |
14 | + | - | - | + | - | NA | - | - | NM+ | + | NA |
15 | + | NA | - | + | NA | NA | NA | NA | NM+ | + | RANBP2-ALK |
16 | + | + | - | + | - | NA | - | - | NM+ | + | RANBP2-ALK |
17 | + | - | NA | - | + | NA | - | NA | PN+ | + | NA |
18 | + | + | - | + | - | - | - | - | NM+ | + | NA |
19 | + | + | - | + | - | - | - | - | NM+ | + | RANBP2-ALK |
20 | NA | NA | NA | NA | NA | NA | NA | NA | NM+ | NA | RANBP2-ALK |
21 | + | - | - | - | - | NA | - | - | NM+ | + | NA |
22 | + | - | NA | - | - | - | - | - | NM+ | + | NA |
23 | + | - | - | - | - | - | - | - | PN+ | + | NA |
24 | + | Focal + | - | - | Focal + | NA | - | - | NM+ | + | NA |
25 | - | + | NA | - | - | - | - | - | NM+ | + | NA |
Total | 86 % (19/22) | 47 % (9/19) | 0 % (0/13) | 61 % (11/18) | 16 % (3/19) | 0 % (0/10) | 0 % (0/19) | 0 % (0/16) | 100 % (25/25) | 100 % (21/21) | 100 % (10/10) |
CK cytokeratin, EMA epithelial membrane antigen, FISH fluroscence in situ hybridization, IHC immunohistochemistry, NA not avaiable, NM nuclear membrane staining, PN cytoplasmic staining with perinuclear accentuation, RT-PCR reverse transcription polymerase chain reaction, SMA smooth muscle actin